Aldeyra Therapeutics(ALDX)

持股变动声明「修正」

Aldeyra Therapeutics(ALDX)04-18 04:15

$Aldeyra Therapeutics(ALDX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-045108  Size: 6 KB 网页链接查看全文

当期报告

Aldeyra Therapeutics(ALDX)04-25 19:05

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-24-035953  Act: 34  Size: 20 MB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069887  Size: 7 KB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069885  Size: 10 KB 网页链接查看全文

当期报告

Aldeyra Therapeutics(ALDX)06-13 19:05

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-24-052234  Act: 34  Size: 219 KB 网页链接查看全文

当期报告

Aldeyra Therapeutics(ALDX)06-20 19:05

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-24-054003  Act: 34  Size: 4 MB 网页链接查看全文

其他

Aldeyra Therapeutics(ALDX)04-23 04:25

$Aldeyra Therapeutics(ALDX)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-104887  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069888  Size: 7 KB 网页链接查看全文

生效批准

Aldeyra Therapeutics(ALDX)04-25 18:05

$Aldeyra Therapeutics(ALDX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001104  Act: 33  Size: 1 KB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069890  Size: 10 KB 网页链接查看全文

网络异常请稍后再试2020-11-20 13:50

$Aldeyra Therapeutics(ALDX)$ 很感兴趣，不过看了看去年12月份开始的日K线，我觉得很难坚持持有查看全文

令狐不冲9992020-10-19 21:10

10.19盘前异动：$Aldeyra Therapeutics(ALDX)$ $Vuzix(VUZI)$ $Eton Pharmaceuticals(ETON)$ OPTT AXGN SBE查看全文

無限月讀2020-07-15 06:36

$Aldeyra Therapeutics(ALDX)$ 收盘买了点查看全文

美美的股2020-07-10 00:56

$Aldeyra Therapeutics(ALDX)$ 准备破茧而出了吗？查看全文

美股滚雪球2020-05-12 21:43

最近疫情股此起彼伏，真是应接不暇 $NanoViricides(NNVC)$ $Aldeyra Therapeutics(ALDX)$ $特斯拉(TSLA)$查看全文

肖恩大侠2020-04-16 00:38

$Aldeyra Therapeutics(ALDX)$ Potential of ADX-629 in COVID-19 lifts Aldeyra, up 14% premarket
Apr. 14, 2020 9:23 AM ET|About: Aldeyra Therapeutics, ... (ALDX)|By: Douglas W. House, SA News Editor
Thinly traded nano cap Aldeyra Therapeutics (NASDAQ:ALDX) is up 14% prem...查看全文

chuminhua2020-03-13 18:04

3/12，Aldeyra Therapeutics$Aldeyra Therapeutics(ALDX)$ 决定暂停两个药物的临床开发，以维持其现金流至年底。暂停的项目包括2018年开始的小分子RASP抑制剂reproxalap皮肤制剂治疗Sjogren-Larsson综合征的III期研究，以及热休克蛋白90的抑制剂ADX-1612原计划Q4进入的移植后淋巴增生综合症II期研...查看全文

牛唐2020-01-24 10:49

$Kala制药(KALA)$ 这一波run up真强势。$Aldeyra Therapeutics(ALDX)$ $N泽璟(SH688266)$查看全文

狂拉的麦克斯2019-12-03 22:21

$Aldeyra Therapeutics(ALDX)$ Thinly traded micro cap Aldeyra Therapeutics (NASDAQ:ALDX) slumps premarket on increased volume in response to results from the first phase of a two-part Phase 3 clinical trial, RENEW, evaluating topical ophthalmic solution reproxalap, an aldehyde...查看全文

追风筝的鱼roy2019-12-03 20:32

$Aldeyra Therapeutics(ALDX)$ 等着出数据了。。。。查看全文

Aldeyra Therapeutics(ALDX.US)RASP抑制剂上市申请获FDA接受

智通财经APP获悉，2月7日，Aldeyra Therapeutics(ALDX.US)宣布FDA已接受其在研眼药水Reproxalap治疗干眼症的新药申请。FDA预计在2023年11月23日前完成审查。据悉，Reproxalap是一种潜在首创小分子促炎性活性醛类物质(RASP)抑制剂，能降... 网页链接

当期报告

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-24-054003  Act: 34  Size: 4 MB 网页链接

当期报告

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-24-052234  Act: 34  Size: 219 KB 网页链接

当期报告

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-157328  Act: 34  Size: 154 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069900  Size: 10 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069874  Size: 10 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069885  Size: 10 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069887  Size: 7 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069888  Size: 7 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069890  Size: 10 KB 网页链接

季度财报

$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-052056  Act: 34  Size: 6 MB 网页链接